U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 47631 - 47640 of 55039 results

Group 1 Specified Substance
Status:
Possibly Marketed Outside US

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
Possibly Marketed Outside US

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
Possibly Marketed Outside US

Class:
G1 SPECIFIED SUBSTANCE

Concept
Status:
US Approved Rx (2014)
Source:
BLA125549
(2014)
Source URL:
First approved in 2014
Source:
BLA125549
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:lanoracopan [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:pasodacigib [INN]
Source URL:

Class:
CONCEPT

Showing 47631 - 47640 of 55039 results